Some recent analyst ratings include

• 10/30/2019-
  Acer Therapeutics Inc (NASDAQ:ACER) had its Buy rating reiterated by HC Wainwright
• 8/2/2019-
  Acer Therapeutics Inc (NASDAQ:ACER) had its Hold ➝ Neutral rating reiterated by William Blair
• 6/25/2019-
  Acer Therapeutics Inc (NASDAQ:ACER) gets downgraded to Market Perform by Raymond James
• 6/25/2019-
  Acer Therapeutics Inc (NASDAQ:ACER) gets downgraded to Hold by Needham & Company LLC

• On 7/3/2019 Steve Aselage, Director, bought 5,000 with an average share price of $3.72 per share and the total transaction amounting to $18,600.00.
• On 8/1/2018 Life Science Ventures Vii Tvm, Director, bought 275,000 with an average share price of $18.00 per share and the total transaction amounting to $4,950,000.00.
• On 12/14/2017 Steve Aselage, Director, bought 2,000 with an average share price of $12.00 per share and the total transaction amounting to $24,000.00.
• On 11/18/2016 Timothy C Barabe, Director, sold 14,914 with an average share price of $0.55 per share and the total transaction amounting to $8,202.70.
• On 9/17/2014 Timothy C Barabe, Director, bought 10,000 with an average share price of $1.15 per share and the total transaction amounting to $11,500.00.
• On 9/16/2014 Neil K Warma, CEO, bought 10,000 with an average share price of $1.11 per share and the total transaction amounting to $11,100.00.
• On 12/18/2013 Karthik Radhakrishnan, CFO, bought 8,000 with an average share price of $1.70 per share and the total transaction amounting to $13,600.00.

Recent Trading Activity for